Business context and reporting period
Ichor Holdings, Ltd. (NASDAQ: ICHR) filed its Form 10-K for the 52-week fiscal year ended December 27, 2019. It designs and manufactures gas and chemical delivery systems, subsystems and components for semiconductor capital-equipment makers. The annual figures below are audited; fourth-quarter figures are unaudited.
Financial performance
| Metric | FY 2019 | FY 2018 |
|---|---|---|
| Net sales | $620.8 million | $823.6 million |
| Gross profit / margin | $86.4 million / 13.9% | $136.1 million / 16.5% |
| Operating income / margin | $15.0 million / 2.4% | $64.0 million / 7.8% |
| Net income from continuing operations | $10.7 million | $57.9 million |
| Diluted EPS from continuing operations | $0.47 | $2.30 |
| Operating cash flow | $57.2 million | $60.5 million |
| Capital expenditures | $12.3 million | $13.9 million |
FY 2019 non-GAAP adjusted net income was $28.3 million and adjusted diluted EPS was $1.25, versus $75.1 million and $2.99 in 2018. These are non-GAAP measures; the company’s reconciliation includes adjustments such as amortization, share-based compensation and certain non-recurring items.
At year-end, cash was $60.6 million, working capital was $113.1 million, and total debt principal was $181.0 million ($8.8 million due within 12 months). Long-term debt, net of issuance costs and current portion, was $169.3 million. Debt matures in 2023; the credit facilities are secured and include leverage and fixed-charge coverage covenants. Management said cash, revolver availability and operating cash flows should cover anticipated needs for at least 12 months.
Fourth-quarter 2019 sales were $189.4 million, gross profit $25.9 million (13.7% margin), operating income $5.7 million, net income $8.0 million and diluted EPS $0.35. In Q4 2018, sales were $141.4 million, gross margin 15.2%, net income $3.5 million and diluted EPS $0.15.
Material changes versus comparable periods
- Annual sales fell 24.6% in 2019, primarily reflecting lower semiconductor capital-equipment demand during much of the year; management cited market-share gains as a partial offset.
- Gross margin declined 260 basis points to 13.9%, attributed to lower factory utilization and product mix. Operating income fell 76.6%, reflecting lower volume and reduced operating leverage.
- Interest expense rose to $10.6 million from $10.0 million, primarily as the weighted-average borrowing rate increased to 4.78% from 4.36%.
- Operating cash flow remained substantial, but included a $68.0 million increase in accounts payable, partly offset by a $44.6 million increase in receivables. Cash increased by $16.8 million during the year.
- Debt principal declined by $23.8 million through net repayments. The company spent $1.6 million on share repurchases in 2019, compared with $90.0 million in 2018.
- Q4 sales rose sequentially from $154.5 million in Q3 2019 and exceeded Q4 2018, but annual results remained materially below 2018.
Outlook, risks and unusual items
The filing provides no quantified revenue, earnings or margin guidance. Management described continued investment in R&D and product development, including expansion into chemical delivery, and expects R&D and selling expenses to rise in absolute dollars as the business develops markets and products.
- Customer concentration is pronounced: Lam Research represented 51% and Applied Materials 33% of 2019 sales. The company generally sells on purchase orders, without long-term minimum-volume commitments.
- Demand is exposed to semiconductor-industry cyclicality, customer order changes, pricing pressure and OEM outsourcing decisions. COVID-19 was identified as an emerging risk in the filing, with its operational and financial impact then uncertain.
- Other disclosed risks include supplier concentration and component availability, manufacturing and product-quality issues, foreign currency and trade-policy exposures, and debt covenant and interest-rate risks. A hypothetical 1% rate change would have affected 2019 interest expense by approximately $1.8 million.
- A supplier-impersonation phishing scam led to transfers to unauthorized accounts in 2019. The company reported full recovery and no financial-statement loss, and said the related material weakness in cash-transfer controls was remediated by year-end.
- FY 2019 income tax benefit was $6.5 million, including the Singapore tax holiday and other tax items. Management noted that proposed IRS rules could require a valuation allowance of approximately $1.7 million against foreign tax-credit deferred tax assets if finalized without changes.
- Management reported no material legal proceedings. The auditor issued an unqualified opinion on the financial statements; the auditor did not attest to internal control over financial reporting, consistent with the company’s emerging-growth-company status.
Important facts for investors to verify
- Whether semiconductor equipment demand and Ichor’s sales recovery persisted after fiscal year-end, particularly given the COVID-19 risk discussed in the filing.
- Whether customer concentration, order volatility and pricing pressure affect margins, utilization and cash conversion.
- How much of operating cash flow is sustainable after considering the large year-end increase in accounts payable and receivables.
- Debt repayment capacity, covenant headroom, variable-rate exposure and the 2023 maturity.
- Progress and commercial contribution from chemical-delivery products and the 2019 developed flow-controller technology purchase.
- Whether the remediated funds-transfer controls continue to operate effectively and whether the potential foreign tax-credit valuation allowance is required.